These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38652965)

  • 1. The immunostimulatory roles of gold nanoparticles in immunization and vaccination against Brucella abortus antigens.
    Staroverov SA; Vyrshchikov RD; Bogatyrev VA; Dykman LA
    Int Immunopharmacol; 2024 May; 133():112121. PubMed ID: 38652965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
    Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.
    Dabral N; Martha-Moreno-Lafont ; Sriranganathan N; Vemulapalli R
    PLoS One; 2014; 9(9):e107180. PubMed ID: 25225910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19.
    Shim S; Soh SH; Im YB; Park HE; Cho CS; Kim S; Yoo HS
    Int J Med Microbiol; 2020 Jan; 310(1):151362. PubMed ID: 31676233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int J Nanomedicine; 2020; 15():3877-3886. PubMed ID: 32581535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice.
    Li X; Xu J; Xie Y; Qiu Y; Fu S; Yuan X; Ke Y; Yu S; Du X; Cui M; Chen Y; Wang T; Wang Z; Yu Y; Huang K; Huang L; Peng G; Chen Z; Wang Y
    Vet Microbiol; 2012 Dec; 161(1-2):137-44. PubMed ID: 22854331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection.
    Lowry JE; Isaak DD; Leonhardt JA; Vernati G; Pate JC; Andrews GP
    PLoS One; 2011 Mar; 6(3):e17425. PubMed ID: 21412420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species.
    Mohammadi E; Golchin M
    Comp Immunol Microbiol Infect Dis; 2020 Jun; 70():101470. PubMed ID: 32208191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucella abortus RB51 and hot saline extract from Brucella ovis as antigens in a complement fixation test used To detect sheep vaccinated with Brucella abortus RB51.
    Adone R; Ciuchini F
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):119-22. PubMed ID: 11139204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.